Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients

Luo, Xin-lan; Wang, Wei; Hu, Shengshou; Sun, Hao; Gao, Huawei; Long, Cun; Song, Yue; Xu, Jianping

doi:10.1510/icvts.2008.197681

Cited by 63 publications

(58 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Komplikationen während ECMO-Therapie werden mit einer Inzidenz von bis zu 75 % beobachtet [23,[28][29][30]. Eine Auflis- [31], Ischämien sind besonders bei Patienten mit peripherer arterieller Verschlußkrankheit häufig [32].…”

Section: Komplikationen Und Komplikationsmanagementunclassified

Positionspapier der Österreichischen Kardiologischen Gesellschaft zum Einsatz der extrakorporalen Membranoxygenation (ECMO) bei Erwachsenen kardiologischen Patienten

Pichler

Antretter

Dünser

et al. 2015

Med Klin Intensivmed Notfmed

View full text Add to dashboard Cite

The use of ECMO to stabilize critically ill patients with severely depressed cardiac function and hemodynamics increased in the last years due to broader availability, better performance and easier implantation of the devices. The present guidelines of the Austrian Society of Cardiology focus on the use of ECMO in adult non-operated patients with cardiac diseases. Not only indications and contraindications are highlighted, but also the equally important issues of monitoring, complication management, measures during implantation and operation, and weaning of the devices are treated in detail. Thereby the present guidelines aim to optimize the use of ECMO in the individual centers, and aim to help current non-ECMO centers in developing a local ECMO-program or to contact ECMO-centers for discussion of individual patients.

show abstract

Section: Komplikationen Und Komplikationsmanagementunclassified

Positionspapier der Österreichischen Kardiologischen Gesellschaft zum Einsatz der extrakorporalen Membranoxygenation (ECMO) bei Erwachsenen kardiologischen Patienten

Pichler

Antretter

Dünser

et al. 2015

Med Klin Intensivmed Notfmed

View full text Add to dashboard Cite

show abstract

“…Supporting data are case series from multiple countries [36][37][38][39][40][41]. In one study involving 45 patients with refractory cardiogenic shock, ECMO was associated with survival to hospital discharge in 29% (13/45) versus the expected total absence of survival without ECMO [40].…”

Section: Two Types Of Ecmo Have Been Developed: Veno-arterial Extracomentioning

confidence: 99%

Role of New Therapies in Reducing Mortality and Major Morbidity in Patients with Systolic Heart Failure

Yurevich¹,

Borer²

2017

The Role of the Clinical Cardiac Electrophysiologist in the Management of Congestive Heart Failure

View full text Add to dashboard Cite

Though heart failure therapies, particularly for systolic heart failure, have developed rapidly and markedly during the past four decades, a need for additional relief persists and is progressively being met. Two new drugs have been approved for marketing in the United States within the past two years, and two other glucose lowering therapies for diabetes appear to have efficacy for heart failure as well. In addition, device therapy for heart failure has progressed markedly during the past 5 years, particularly in refinements of the indications and applications of devices to minimize symptoms and hospitalizations and to maximize survival. This chapter will outline these recent developments.

show abstract

“…Complications may be related to the mandatory use of anticoagulation (bleeding, thromboembolism), mechanical shear stress on cellular blood components (haemolysis) and long-term infections of the implanted materials (drive line, cannulas, device). 25,26,[29][30][31][32][33] A summary of the advantages and risks of ECLS is provided in Table 2.…”

Section: Evaluate Mechanical Supportmentioning

confidence: 99%

Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days

Hauffe¹,

Krüger²,

Béttex³

et al. 2016

Cardiac Failure Review

View full text Add to dashboard Cite

Shock in cardio-surgical intensive care unit (ICU) patients requires prompt identification of the underlying condition and timely therapeutic interventions. Management during the first 6 hours, also referred to as “the golden hours”, is of paramount importance to reverse the shock state and improve the patient’s outcome. The authors have previously described a state-of-the-art diagnostic work-up and discussed how to optimise preload, vascular tone, contractility, heart rate and oxygen delivery during this phase. Ideally, shock can be reversed during this initial period. However, some patients might have developed multiple organ dysfunction, which persists beyond the first 6 hours despite the early haemodynamic treatment goals having been accomplished. This period, also referred to as “the silver days”, is the focus of this review. The authors discuss how to reduce vasopressor load and how to minimise adrenergic stress by using alternative inotropes, extracorporeal life-support and short acting beta-blockers. The review incorporates data on fluid weaning, safe ventilation, daily interruption of sedation, delirium management and early rehabilitation. It includes practical recommendations in areas where the evidence is scarce or controversial. Although the focus is on cardio-surgery ICU patients, most of the considerations apply to critical ill patients in general.

show abstract

Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients

Cited by 63 publications

References 11 publications

Positionspapier der Österreichischen Kardiologischen Gesellschaft zum Einsatz der extrakorporalen Membranoxygenation (ECMO) bei Erwachsenen kardiologischen Patienten

Positionspapier der Österreichischen Kardiologischen Gesellschaft zum Einsatz der extrakorporalen Membranoxygenation (ECMO) bei Erwachsenen kardiologischen Patienten

Role of New Therapies in Reducing Mortality and Major Morbidity in Patients with Systolic Heart Failure

Shock Management for Cardio-surgical Intensive Care Unit Patient: The Silver Days

Contact Info

Product

Resources

About